Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Clinical trial NCT04262336 · COMPLETED
Trial details
- NCT number
- NCT04262336
- Sponsor
- Decibel Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-21
- Primary completion
- 2022-07-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.